Analystreport

Sangamo Therapeutics Inc (NASDAQ: SGMO) had its "hold" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.

Sangamo Therapeutics, Inc.  (SGMO) 
Last sangamo therapeutics, inc. earnings: 2/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sangamo.com